Doxorubicin, a widely used chemotherapeutic agent known to regulate DNA damage, cell-cycle arrest, and apoptosis, can perturb the expression of several cancer driver genes (GADD45B, UHRF1, CDC6, etc.)that are involved in cell-cycle regulation, from this high-throughput data analysis. The gene discussed is CDC6; the disease is cancer.